These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 9387666
1. [Serum adrenaline and noradrenaline levels in cirrhosis patients with portal hypertension]. Zhu J, Du R, Leng X. Zhonghua Wai Ke Za Zhi; 1996 Mar; 34(3):144-6. PubMed ID: 9387666 [Abstract] [Full Text] [Related]
2. Serum levels of epinephrine and norepinephrine in cirrhotic patients with portal hypertension. Zhu J, Leng X, Zhao H, Chen L, Du R. Chin Med J (Engl); 1998 Jun; 111(6):504-6. PubMed ID: 11245067 [Abstract] [Full Text] [Related]
3. Plasma catecholamines in patients with presinusoidal portal hypertension: comparison with cirrhotic patients and nonportal hypertensive subjects. Gaudin C, Braillon A, Poo JL, Kleber G, Moreau R, Lebrec D. Hepatology; 1991 May; 13(5):913-6. PubMed ID: 2029995 [Abstract] [Full Text] [Related]
4. Effect of sympathetic and plasma renin activity on hemodialysis hypertension. Grekas D, Kalevrosoglou I, Karamouzis M, Geropoulou E, Kabouris H, Tourkantonis A. Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674 [Abstract] [Full Text] [Related]
5. [Plasma prostacyclin (PGI2) levels in peripheral venous, arterial and portal venous blood in cirrhotic patients with portal hypertension and their clinical implication]. Yin J, Leng X, Zhu J. Zhonghua Wai Ke Za Zhi; 1995 Sep; 33(9):563-5. PubMed ID: 8731881 [Abstract] [Full Text] [Related]
6. Correlations of portal hypertensive gastropathy of hepatitis B cirrhosis with other factors. Pan WD, Xun RY, Chen YM. Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):527-31. PubMed ID: 14607680 [Abstract] [Full Text] [Related]
7. [Plasma level of glucagon in cirrhotic patients with portal hypertension during operation of portacaval shunts]. Feng H, Zhang Z, Leng X, Li S, Zhu J, Du R. Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):222-4. PubMed ID: 11829825 [Abstract] [Full Text] [Related]
8. Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients. Praticò D, Rossi E, Merli M, Riggio O, FitzGerald GA, Violi F. J Investig Med; 1998 Dec; 46(9):430-4. PubMed ID: 9861778 [Abstract] [Full Text] [Related]
9. Plasma levels of cavernous and systemic norepinephrine and epinephrine in men during different phases of penile erection. Becker AJ, Uckert S, Stief CG, Truss MC, Machtens S, Scheller F, Knapp WH, Hartmann U, Jonas U. J Urol; 2000 Aug; 164(2):573-7. PubMed ID: 10893646 [Abstract] [Full Text] [Related]
10. Evidence of increased peripheral catecholamine release in patients with long-standing, untreated essential hypertension. Kjeldsen SE, Flaaten B, Eide I, Helgeland A, Leren P. Scand J Clin Lab Invest; 1982 May; 42(3):217-23. PubMed ID: 7134805 [Abstract] [Full Text] [Related]
11. Plasma norepinephrine and epinephrine levels in essential hypertension. Goldstein DS, Lake CR. Fed Proc; 1984 Jan; 43(1):57-61. PubMed ID: 6690339 [Abstract] [Full Text] [Related]
12. Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India. Chittiprol S, Kumar AM, Satishchandra P, Taranath Shetty K, Bhimasena Rao RS, Subbakrishna DK, Philip M, Satish KS, Ravi Kumar H, Kumar M. Psychoneuroendocrinology; 2008 Jan; 33(1):30-40. PubMed ID: 17993249 [Abstract] [Full Text] [Related]
13. Portal vein hemodynamics in cirrhotic patients with portal hypertensive gastropathy: an echo-Doppler study. Iwao T, Toyonaga A, Ikegami M, Sumino M, Oho K, Shigemori H, Sakaki M, Nakayama M, Tanikawa K, Iwao J. Hepatogastroenterology; 1994 Jun; 41(3):230-4. PubMed ID: 7959544 [Abstract] [Full Text] [Related]
14. Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites. Alam I, Bass NM, Bacchetti P, Gee L, Rockey DC. Am J Gastroenterol; 2000 Jan; 95(1):199-203. PubMed ID: 10638583 [Abstract] [Full Text] [Related]
15. Splanchnic and systemic haemodynamic response to volume changes in patients with cirrhosis and portal hypertension. Vlavianos P, Mac Mathuna P, Williams R, Westaby D. Clin Sci (Lond); 1999 May; 96(5):475-81. PubMed ID: 10209079 [Abstract] [Full Text] [Related]
16. Plasma catecholamines and adrenoceptors in young hypertensive patients. Müller R, Steffen HM, Weller P, Krone W. J Hum Hypertens; 1994 May; 8(5):351-5. PubMed ID: 8064782 [Abstract] [Full Text] [Related]
17. Beta-endorphin and catecholamine concentrations during chronic and acute stress in intensive care patients. Schmidt C, Kraft K. Eur J Med Res; 1996 Sep 20; 1(11):528-32. PubMed ID: 9438155 [Abstract] [Full Text] [Related]
18. Altered basal and postprandial plasma melatonin, gastrin, ghrelin, leptin and insulin in patients with liver cirrhosis and portal hypertension without and with oral administration of melatonin or tryptophan. Celinski K, Konturek PC, Slomka M, Cichoz-Lach H, Gonciarz M, Bielanski W, Reiter RJ, Konturek SJ. J Pineal Res; 2009 May 20; 46(4):408-14. PubMed ID: 19552764 [Abstract] [Full Text] [Related]
19. [The role of nitric oxide in the pathogenesis of portal hypertension]. Zhu J, Wang D, Leng X, Zhang Z, Wang F, Peng J, Du R. Zhonghua Wai Ke Za Zhi; 2000 Feb 20; 38(2):95-7. PubMed ID: 11831997 [Abstract] [Full Text] [Related]
20. [Expression of local angiotensinogen mRNA and activation of local nuclear factor-kappaB in vasculopathy of portal hypertension]. Sun Z, Yang Z, Xu JY. Zhonghua Yi Xue Za Zhi; 2005 Aug 24; 85(32):2283-6. PubMed ID: 16321211 [Abstract] [Full Text] [Related] Page: [Next] [New Search]